Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03823885 · ClinicalTrials.gov registry record · NA
ECigs, Inflammation and Oxidative Stress
A NA study of E-cigarettes, Oxidative Stress, Inflammation, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
- 1
- Study location
NCT03823885 is a NA study of E-cigarettes, Oxidative Stress, Inflammation that has completed, run by University of California, Los Angeles. The registered enrollment target is 148 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03823885, a NA study of E-cigarettes, Oxidative Stress, Inflammation, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
- 1
- Study location
Study Summary
Randomized controlled trial of acute use of electronic cigarette effect on oxidative stress and inflammation.
Conditions Studied
Interventions
- OTHER e-cigarette
- OTHER empty (-cigarette sham control)
Study Locations (1)
California
- UCLA - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2019-02-08 |
| Est. Completion | 2023-10-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03823885
The ClinicalTrials.gov registry entry for NCT03823885 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with E-cigarettes, Oxidative Stress, Inflammation appearing as the primary indexed condition, and to 2 interventions - of which e-cigarette is the first listed.
NCT03823885 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT03823885 about?
NCT03823885 is a clinical study titled "ECigs, Inflammation and Oxidative Stress". Randomized controlled trial of acute use of electronic cigarette effect on oxidative stress and inflammation.
What is the current status of trial NCT03823885?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2019-02-08. Estimated completion is 2023-10-01.
What conditions does trial NCT03823885 study?
This clinical trial studies the following conditions: E-cigarettes, Oxidative Stress, Inflammation.
What interventions are being tested in trial NCT03823885?
The interventions under investigation include: e-cigarette (OTHER), empty (-cigarette sham control) (OTHER).
Who is sponsoring clinical trial NCT03823885?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03823885 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.